Kimberly MacGorman

Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects

S. Zhou, M. Palmisano, K. Ogasawara, 2019, Journal of clinical pharmacology.

Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects

S. Surapaneni, M. Palmisano, Ying Ye, 2020, European Journal of Clinical Pharmacology.

Single‐Dose Pharmacokinetics, Safety, and Tolerability of Avadomide (CC‐122) in Subjects With Mild, Moderate, or Severe Renal Impairment

S. Zhou, M. Palmisano, Kimberly MacGorman, 2019, Clinical pharmacology in drug development.